Show simple item record

dc.contributor.authorRaina, DB
dc.contributor.authorSirka, A
dc.contributor.authorQayoom, I
dc.contributor.authorTeotia, AK
dc.contributor.authorLiu, Y
dc.contributor.authorTarasevicius, S
dc.contributor.authorTanner, KE
dc.contributor.authorIsaksson, H
dc.contributor.authorKumar, A
dc.contributor.authorTägil, M
dc.contributor.authorLidgren, L
dc.date.accessioned2020-05-13T15:00:33Z
dc.date.available2020-03-27
dc.date.available2020-05-13T15:00:33Z
dc.date.issued2020-04-03
dc.identifier.citationRaina, Deepak Bushan et al. "Long Term Response To A Bioactive Biphasic Biomaterial In The Femoral Neck Of Osteoporotic Rats". Tissue Engineering Part A, 2020. Mary Ann Liebert Inc, doi:10.1089/ten.tea.2020.0018. Accessed 13 May 2020.en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/64070
dc.description.abstractOsteoporosis often leads to fragility fractures of the hip resulting in impaired quality of life and increased mortality. Augmenting the proximal femur could be an attractive option for prevention of fracture or fixation device failure. We describe a tissue engineering based strategy to enhance long-term bone formation in the femoral neck of osteoporotic rats by locally delivering bioactive molecules; bone morphogenic protein-2 (rhBMP-2) and zoledronic acid (ZA) using a calcium sulphate/hydroxyapatite (CaS/HA) biomaterial. A defect was created by reaming the femoral neck canal of osteoporotic (OVX) rats and they were treated as follows: G1. Empty, G2. CaS/HA, G3. CaS/HA + Systemic ZA, G4. CaS/HA + Local ZA and G5. CaS/HA + Local ZA + rhBMP-2. Bone formation was evaluated 6 months after treatment. Furthermore, radioactively labelled 14C-ZA was used to study the bioavailability of ZA at the defect location, which was determined using scintillation counting. Micro-CT indicated significantly higher bone volume (BV) in groups G4 and G5 compared to the other treatment groups. This was confirmed qualitatively by histological assessment. Addition of rhBMP-2 gave no additional benefit in this model. Local delivery of ZA performed better than systemic administration of ZA. Mechanical testing showed no differences between the groups, likely reflecting that the addition of bioactive molecules had limited effect on cortical bone or the choice of mechanical testing setup was not optimal. Scintillation counting revealed higher amounts of 14C-ZA present in the treated leg of G4 compared to its contralateral control and compared to G3 indicating that local ZA delivery can be used to achieve high local concentrations without causing a systemic effect. This long-term study shows that local delivery of ZA using a CaS/HA carrier can regenerate cancellous bone in the femoral neck canal and has clear implications for enhancing implant integration and fixation in fragile bone.en_US
dc.languageeng
dc.publisherMary Ann Lieberten_US
dc.relation.ispartofTissue Eng Part A
dc.rightsThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.titleLong Term Response to a Bioactive Biphasic Biomaterial in the Femoral Neck of Osteoporotic Rats.en_US
dc.typeArticleen_US
dc.rights.holder© The Author(s) 2020
dc.identifier.doi10.1089/ten.TEA.2020.0018
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/32242474en_US
pubs.notesNot knownen_US
pubs.publication-statusPublished onlineen_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Except where otherwise noted, this item's license is described as This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.